Dr Lal PathLabs Q2 Results: Dr Lal PathLabs Limited, a prominent player in the Indian diagnostic and healthcare service sector, has reported a notable financial performance for the second quarter of ...

Dr Lal PathLabs bonus shares: Healthcare Services player Dr Lal PathLabs might be showing up to 50 per cent fall in some trading apps today as all these the shares turned ex-bonus, adjusting to the ...

Earnings call Dr. Lal PathLabs reported Q2 FY26 revenue of ₹731 crore, up 10.7% YoY, with PAT rising 16.4% to ₹152 crore and EBITDA margin stable at 30.7%. Management reaffirmed FY26 revenue growth ...

Dr Lal PathLabs on Friday announced its Q3 results, reporting a year-on-year increase in revenue while net profit declined. Dr Lal PathLabs on Friday announced its Q3 results. Image Credit: Freepik Dr ...

Bengaluru: Dr. Lal Path Labs reported a ‍lower third-quarter profit on Friday after taking a one-time charge ⁠linked to India's new labour code, despite strong demand for its bundled test packages.

April 25 (Reuters) - Dr Lal Path Labs (DLPA.NS), opens new tab, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its ...

Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...

The shares of Dr Lal PathLabs jumped more than 3 percent on October 27. This comes after the company announced that its board is set to meet on October 31 to consider a bonus issue of shares. The ...

Dr. Lal PathLabs is lining up a decisive acquisition drive to consolidate India’s hyper‑local diagnostics market, with Group CFO and International CEO Ved Goel signalling that the company is now “a ...

Earnings call Dr. Lal PathLabs reported Q3 FY25 revenue of ₹597 crore, up 10.7% YoY, with EBITDA margin at 25.8% and PAT up 19.3% YoY. Growth was driven by volume gains, improved mix, and Swasthfit ...